Evaluation of serum and urine 1,5-anhydro-D-glucitol and myo-inositol concentrations in healthy dogs.

1,5-anhydro-D-glucitol (1,5AG) is a pyranoid polyol compound found in human circulating blood. Myo-inositol (MI) is a stereoisomer of inositol and serves as a precursor of inositol phospholipids. 1,5AG and MI are filtered by the glomerulus and almost completely reabsorbed through the renal tubules. However, under hyperglycemic conditions, reabsorption through the renal tubules is competitively inhibited because the structures of 1,5AG and MI resemble that of glucose. In this study, we investigated the kinetics of serum and urine 1,5AG and MI levels in healthy dogs. We demonstrated that 1,5AG and MI exist in canine serum and urine by gas chromatography-mass spectrometry. Under continuous hyperglycemic conditions, the serum 1,5AG concentration in healthy dogs decreased while the serum MI concentration remained unchanged. Urinary excretion of 1,5AG and MI increased significantly after blood glucose concentrations reached 200 to 220 mg/dl. A significant negative correlation was observed between serum 1,5AG and glucose concentrations during hyperglycemia. However, no significant correlation was observed between serum MI and glucose concentrations. In this study, we demonstrated that serum and urine 1,5AG and MI levels were changed by blood glucose concentrations. The serum 1,5AG concentration was decreased by continuous hyperglycemia. However, the serum MI concentration does not reflect hyperglycemia.

[1]  Sun Woo Kim,et al.  1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. , 2009, Diabetes research and clinical practice.

[2]  Shukun Yu The anhydrofructose pathway of glycogen catabolism , 2008, IUBMB life.

[3]  S. Kawazu,et al.  [Detection of glucose intolerance by urinary myo-inositol]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[4]  S. Kawazu,et al.  A study of urinary myo-inositol as a sensitive marker of glucose intolerance. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[5]  Y. Akanuma,et al.  Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients , 1988, Diabetologia.

[6]  Y. Akanuma,et al.  Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients , 1988, Diabetologia.

[7]  D. Loo,et al.  Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus Oocytes , 2004, The Journal of Membrane Biology.

[8]  R. Przybylski,et al.  Urinary chiro-Inositol and myo-inositol Excretion is Elevated in the Diabetic db/db Mouse and Streptozotocin Diabetic Rat , 2003, Experimental biology and medicine.

[9]  D. Gagnon,et al.  Identification of a Novel Na+/myo-Inositol Cotransporter* , 2002, The Journal of Biological Chemistry.

[10]  B. Keevil,et al.  Plasma 1,5‐anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[11]  M. Pedersen,et al.  Analysis of 1,5-anhydro-D-fructose, microthecin, and 4-deoxy-glycero-hexo-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode. , 1999, Analytical biochemistry.

[12]  R. Farese,et al.  In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat. , 1998, Molecules and cells.

[13]  E. Reece,et al.  Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. , 1998, Teratology.

[14]  H. Akanuma,et al.  Purification and some properties of a hepatic NADPH-dependent reductase that specifically acts on 1,5-anhydro-D-fructose. , 1998, Journal of biochemistry.

[15]  J. Nakamura,et al.  [Myo-inositol]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[16]  H. Akanuma,et al.  Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway. , 1996, European journal of biochemistry.

[17]  Y. Akanuma,et al.  Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control. , 1994, Diabetes research and clinical practice.

[18]  M. Haruna,et al.  Effects of 1,5‐anhydro‐D‐fructose on selected glucose‐metabolizing enzymes , 1993, Biotechnology and applied biochemistry.

[19]  H. Akanuma,et al.  Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. , 1992, The American journal of physiology.

[20]  H. Akanuma,et al.  High performance liquid chromatographic determination of 1,5-anhydroglucitol in human plasma for diagnosis of diabetes mellitus. , 1992, Biomedical chromatography : BMC.

[21]  J. Eichberg,et al.  A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Akanuma,et al.  Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents. , 1990, The American journal of physiology.

[23]  Y. Akanuma,et al.  Plasma 1,5-Anhydro-D-Glucitol as New Clinical Marker of Glycemic Control in NIDDM Patients , 1989, Diabetes.

[24]  Y. Akanuma,et al.  Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice. , 1987, Journal of biochemistry.

[25]  Y. Akanuma,et al.  Reduction and Recovery of Plasma 1,5-Anhydro-D-Glucitol Level in Diabetes Mellitus , 1987, Diabetes.

[26]  D. Greene,et al.  Altered Sorbitol and myo‐Inositol Metabolism as the Basis for Defective Protein Kinase C and (Na,K)‐ATPase Regulation in Diabetic Neuropathy a , 1986, Annals of the New York Academy of Sciences.

[27]  O. Takatani,et al.  Variations of 1-deoxyglucose(1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus. , 1983, Clinical chemistry.

[28]  O. Takatani,et al.  Identification and metabolic implication of 1-deoxyglucose (1,5-anhydroglucitol) in human plasma. , 1982, Clinical chemistry.

[29]  E. Pitkänen Serum 1,5-anhydroglucitol in normal subjects and in patients with insulin-dependent diabetes mellitus. , 1982, Scandinavian journal of clinical and laboratory investigation.

[30]  Diethelm Ag,et al.  The metabolism of myo-inositol by the human kidney. , 1979 .

[31]  R. Clements,et al.  The metabolism of myo-inositol by the human kidney. , 1979, The Journal of laboratory and clinical medicine.

[32]  P. Thomas,et al.  Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[33]  R. Clements,et al.  Myoinositol Metabolism in Diabetes Mellitus: Effect of Insulin Treatment , 1977, Diabetes.